The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
about
Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impactEffects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study.Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.Different Quality of Life Between GERD and Barrett's Esophagus (Am J Gastroenterol 2009;104:2695-2703).Systematic review of the risk of enteric infection in patients taking acid suppression.Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease.Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 surveyCost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.Health-related quality of life in patients with Barrett's esophagus.Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases.Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.Assessment of malnutrition in patients with liver cirrhosis using protein calorie malnutrition (PCM) score verses bio-electrical impedance analysis (BIA)
P2860
Q24633952-34AA47D5-4222-41D7-B0DF-8D9C44040DACQ30891494-1006A186-E338-45BF-B797-5BBECFAC501BQ33866695-52C5EF56-0BAC-47FF-A483-7EB4FCE93178Q33890497-00A35A71-2A11-45AD-8DD6-9332B7585B66Q34629190-BEAAE4DF-A4F7-430E-975A-37135DC6D3EFQ34777810-91CDF708-6F20-472E-B9DD-6A410BACB0FEQ35268223-C518BAB1-A64D-4ED9-A50A-3A515E260434Q36722794-27725097-D4E5-4E72-A1B6-494068A2C78FQ37414570-31184106-728B-4B5E-A65D-6F7372A09A6AQ38942866-64458646-3E16-45F5-8438-309776382FC4Q48629907-C42BAC26-2216-46CB-8472-4D4DF44D0FE3Q58803938-7EFDB6D6-0A90-4542-8CAA-B08FDC6D50CB
P2860
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The impact of illness in patie ...... stro-esophageal reflux disease
@ast
The impact of illness in patie ...... stro-esophageal reflux disease
@en
The impact of illness in patie ...... stro-esophageal reflux disease
@nl
type
label
The impact of illness in patie ...... stro-esophageal reflux disease
@ast
The impact of illness in patie ...... stro-esophageal reflux disease
@en
The impact of illness in patie ...... stro-esophageal reflux disease
@nl
prefLabel
The impact of illness in patie ...... stro-esophageal reflux disease
@ast
The impact of illness in patie ...... stro-esophageal reflux disease
@en
The impact of illness in patie ...... stro-esophageal reflux disease
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
The impact of illness in patie ...... stro-esophageal reflux disease
@en
P2093
Alan N Barkun
Alessio Degl'innocenti
Carlo A Fallone
David Armstrong
Diane Heels-Ansdell
Holger J Schünemann
Ingela Wiklund
Lisa Tanser
Naoki Chiba
Peggy Austin
P2860
P2888
P3181
P356
10.1186/1471-230X-5-23
P407
P577
2005-01-01T00:00:00Z
P6179
1009025436